Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jaumdally RJ et al. – High–dose atorvastatin increased circulating CPCs, reduced VEGF and increased Ang–2 in patients with diabetes and CVD, providing another possible pathophysiological mechanism for the beneficial effects of statins in CVD.

Related Articles

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial under treatment of lipid associated cardiovascular risk?
Annals of Rheumatic Diseases, 11/11/09    Relevance Score: 89%

Biphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09    Relevance Score: 89%

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research, 11/03/09    Relevance Score: 88%

Interaction Between Fatness and Fitness on CVD Risk Factors in Asian Youth
International Journal of Sports Medicine, 10/14/09    Relevance Score: 88%

Preventing heart disease in women
Sexuality, Reproduction & Menopause, 10/08/09    Relevance Score: 88%

Today in Clinical Pharmacology...keeping you current

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09

How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/19/09

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/19/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address